IGM Biosciences SG&A Expense (Quarterly) Insights

IGM Biosciences Inc (IGMS)

9.93 -0.10 (-1.00%) USD | NASDAQ | May 07, 16:00

9.93 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	11.58M
September 30, 2023	12.51M
June 30, 2023	12.98M
March 31, 2023	13.00M
December 31, 2022	11.62M
September 30, 2022	12.66M
June 30, 2022	12.37M
March 31, 2022	13.08M
December 31, 2021	11.51M
September 30, 2021	10.00M
June 30, 2021	8.649M

Date	Value
March 31, 2021	8.134M
December 31, 2020	5.14M
September 30, 2020	4.732M
June 30, 2020	4.388M
March 31, 2020	3.99M
December 31, 2019	3.174M
September 30, 2019	2.394M
June 30, 2019	2.228M
March 31, 2019	1.445M
December 31, 2018	1.232M
September 30, 2018	1.373M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.228M

Minimum

Jun 2019

13.08M

Maximum

Mar 2022

8.640M

Average

10.00M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks